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INTRODUCTION
Midurethral tension-free sling procedures recreate the sub-
urethral floor under the midurethra, and this enables coap-
tation of the urethra during increased intraabdominal pres-
sure; this procedure has become popular in recent years for
the treatment of stress urinary incontinence. The tension-free
vaginal tape (TVT) procedure, based on the integral theory
(1-3), was the first midurethral tape procedure and its high
success rate was demonstrated by the recent long-term follow-
up data (4, 5). The TVT procedure has become the treatment
of choice for stress urinary incontinence because it is a mini-
mally invasive operation with a high success rate after long-
term follow-up (6, 7). 
More recently, the innovative replacement of incontinence
surgery (IRIS; B. Braun Korea & Dow Medics Co., Ltd, Seoul,
Korea) procedure has been performed, and this procedure has
been shown to be effective and safe for treating stress urinary
incontinence. However, there have been no previous studies
to compare the long-term outcomes of the IRIS and TVT
procedures. Therefore, we evaluated the efficacy and safety
of the IRIS procedure at the three-year follow-up, and we
compared the results with those of the TVT procedure.
MATERIALS AND METHODS
This retrospective clinical trial was performed at a single
institution. This study included 71 consecutive women who
underwent the IRIS or TVT procedure for the treatment of
objective stress urinary incontinence at the Urology Depart-
ment between February 2002 and April 2003. Among these
patients, 66 were followed up for at least 3 yr (mean follow-
up: 42.5 months, range: 36 to 50 months); the remaining 5
patients could not be followed up because they did not respond
when contacted by mail and telephone. The preoperative eval-
uations included a medical history, physical examination, 3-
day voiding diary, uroflowmetry, post-void residual urine mea-
surement, and complete multi-channel urodynamic investiga-
tion. The urodynamic evaluation consisted of filling and void-
ing cystometry, and the valsalva leak point pressure (VLPP)
and maximal urethral closing pressure (MUCP) measurements.
All the definitions corresponded to those of the Internation-
al Continence Society (8).
The IRIS and TVT procedures were performed under local,
spinal or general anesthesia by one expert surgeon with using
the standard technique with some modifications (3). No spe-
cific criteria were used in selecting one procedure in favor of
the other. 
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Three-year Outcomes of the Innovative Replacement of Incontinence
Surgery Procedure for Treatment of Female Stress Urinary Incontinence:
Comparison with Tension-free Vaginal Tape Procedure
Innovative replacement of incontinence surgery (IRIS) is a polypropylene tape that is
placed beneath the midurethra to restore urinary continence. We evaluated the
long-term efficacy and safety of the IRIS procedure and compared it with tension-
free vaginal tape (TVT) for the treatment of female stress urinary incontinence. We
included all 66 consecutive women who underwent IRIS (n=34) or TVT (n=32) bet-
ween February 2002 and April 2003 and followed them up for at least 3 yr postop-
eratively. The 3-yr success rate was 94.1% for the IRIS and 93.8% for the TVT, and
the satisfaction rates were 91.2% and 90.6%, respectively. Intraoperative compli-
cations for the IRIS group included 3 cases of bladder perforation, and there were
3 cases of bladder perforation in the TVT group. The postoperative complications
for the IRIS group included 2 patients with de novo urgency and one patient with
mesh erosion. Three patients with TVT developed de novo urgency. One case of
each group showed temporary voiding difficulty. On the basis of our results, the IRIS
may be an effective and safe procedure as compared to TVT, with a high success
rate and a low complication rate.
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Postoperatively, a Foley catheter was always inserted for
bladder drainage and the residual urine volume was evaluated
after withdrawal of the Foley catheter. If the post-void resid-
ual volume was more than 150 mL, then intermittent cathe-
terization was proposed. Voiding difficulties were defined as
a residual urine volume of 150 mL or more, as checked by
post-void catheterization. Urgency was defined as the com-
plaint of a sudden compelling desire to pass urine, which was
difficult to defer, and urge incontinence was defined as the
complaint of involuntary leakage accompanied by or imme-
diately preceded by urgency (8).
All patients visited the clinics 1 yr and 3 yr after surgery,
and at each visit they were again evaluated by a medical his-
tory, physical examination, uroflowmetry, and post-void resid-
ual urine measurement. We asked the patient’s overall glob-
al satisfaction at 1 yr and 3 yr. We analyzed the success rates
of the IRIS and TVT procedures for treatment of stress and
mixed urinary incontinence, the patients’ perception of sat-
isfaction, the changes in overactive bladder symptoms after
surgery, and the complications related to surgery.
The ‘cure’ of stress urinary incontinence was defined as an
absence of any episodes of involuntary urine leakage during
stressful activities and a stress cough test. ‘Improvement’ was
defined as a significant reduction of urine leakage, and so the
patient didn’t require further treatment (9). ‘Failure’ was de-
fined as unchanged or exacerbated urine leakage. For the suc-
cess rates, cure or improvement were considered as success.
The patients’ perception of satisfaction was categorized as
‘very satisfied’, ‘satisfied’, ‘so-so’ and ‘dissatisfied’, with both
‘very satisfied’ and ‘satisfied’ scored as satisfaction. Safety data
were collected during the entire follow-up period. In this
trial, the success and satisfaction rates were the primary end-
points of the study. 
All statistical analyses were performed with the Statistical
Package for the Social Sciences (version 12.0), and they are
presented as either the mean±standard deviation or the fre-
quency (percentage). The differences between the IRIS and
TVT groups in perioperative and postoperative results, includ-
ing the surgical outcomes were compared using Student’s t-
test and the chi-square test. A p value below 0.05 was con-
sidered statistically significant for all comparisons.
RESULTS
Table 1 shows the characteristics of the 66 patients. No
significant baseline differences were found between the IRIS
and TVT groups.
No statistical significant difference was found in the fol-
low-up period (41.6±1.7 months vs. 43.2±2.1 months,
respectively), the mean operative time (26.6±4.1 min vs.
27.5±2.7 min, respectively), the hospital stay (2.6±0.9
days vs. 2.5±0.9 days, respectively), and the period of catheter
indwelling (1.5±0.6 days vs. 1.1±0.4 days, respectively)
between the two groups (Table 2).
There was no statistically significant difference in the pre-
operative and postoperative uroflowmetry results of the two
procedures. For both groups, the maximal flow rate dropped
significantly at 7-day after the operation (p=0.002 vs. 0.026).
Over time, however, the maximal flow rate increased gradu-
ally and it was similar to the preoperative flow rate at 3-yr.
Residual urine increased significantly at postoperative 7-day
and this decreased at 1-yr and 3-yr in both groups (Table 3). 
The success rates and satisfaction rates in these 66 women
are presented in Table 4. The overall 1-yr and 3-yr success
rates were 97.0% and 93.9%, respectively. At 1 yr and 3 yr,
the IRIS and TVT had similar success rates (97.1% and 94.1%
vs. 96.9% and 93.8%, respectively). Furthermore, at 1 yr and
3 yr, there was no statistical difference in the satisfaction rates
of the two procedures (94.1% vs. 93.8% and 91.2% vs. 90.6
%, respectively) (Table 4).
Both groups had similar perioperative and postoperative
complications. There were no bowel, nerve or major vessel
injuries in either groups (Table 5). Three patients in each group
(8.8% vs. 9.3%, respectively) had bladder perforation, which
Values are presented as mean±standard deviation or number (%). Data
were evaluated using Student t-test and chi-square test.
IRIS, Innovative replacement of incontinence surgery; TVT, Tension-free
vaginal tape; BMI, Body mass index.
Characteristic IRIS TVT p value
Number 34 32
Mean age (yr) 51.8±7.1 53.0±9.3 0.557
Parity 2.8±0.9 3.1±0.9 0.418
Mean BMI (kg/m
2) 22.6±3.1 23.4±2.4 0.099
Menopause 11 (32.4) 12 (37.5) 0.661
Duration of symptom (yr) 4.8±0.7 5.3±0.8 0.681
Previous pelvic surgery (%) 5 (14.7) 6 (18.8) 0.268
Sling surgery 2 2 0.950
Bruch operation 0 1 0.299
Hysterectomy 1 3 0.274
Others 2 0 0.164
Mixed incontinence (%) 3 (8.8) 5 (15.6) 0.397
Stamey grade (%) 0.780
I 11 (32.4) 9 (28.1) 0.709
II 22 (64.7) 21 (65.6) 0.938
III 1 (2.9) 2 (6.3) 0.519
Table 1. Characteristics of the patients
Values are presented as mean±SD. Data were evaluated using Stu-
dent’s t-test.
IRIS, Innovative replacement of incontinence surgery; TVT, Tension-free
vaginal tape.
Characteristic IRIS (n=34) TVT (n=32) p value
Follow-up period (months) 41.6±1.7 43.2±2.1 0.492
Operation time (min) 26.6±4.1 27.5±2.7 0.142
Hospital stay (days) 2.6±0.9 2.5±0.9 0.662
Catheter indwelling (days) 1.4±0.6 1.2±0.4 0.108
Table 2. Comparisons of operative and postoperative courseThree-year Outcomes of IRIS Procedure 499
was managed with an indwelling urinary catheter for 1-3 days.
Two patients (5.8%) in the IRIS group and three (9.3%) in
TVT group developed de novo urgency or urge incontinence,
and one patient in each group (2.9% vs. 3.1%, respectively)
developed transient voiding difficulties. There was one other
complication in IRIS group: one patient (2.9%) experienced
tape erosion into the vagina that required partial tape removal.
After tape removal, the patient experienced recurred urine
leakage that was about the same as her preoperative condition.
The mean follow-up period of 5 patients (n=2 vs. 3, res-
pectively), who could not be followed up for 3 yr, was 6 mon-
ths (range: 3 to 13 months). Until the follow-up, their results
were included as successful and there were no complications.
DISCUSSION
Stress urinary incontinence (SUI) is a common problem
among women, particularly after childbearing. The surgical
procedures used for the management of women with severe
stress urinary incontinence are urethral bulking agents, sub-
urethral sling procedures, and colposuspension such as the
Burch operation. The TVT procedure is based on the integral
theory and was first described in 1996 (3); it has become pop-
ular for the treatment of stress urinary incontinence due to
its high success rates (4-7), in addition to its simplicity and
minimal invasiveness. Many surgeons have adopted midure-
thral tape procedures as their primary operation for treating
stress urinary incontinence (10). While most of the published
literature has focused on TVT, numerous other midurethral
systems are presently being introduced for the treatment of
stress urinary incontinence. It is important to demonstrate
equivalent efficacy and safety for these different procedures.
The instrument of the IRIS system is comprised of a non-
disposable metal handle to which two metal needles can be
attached. The needles have an outer diameter of 5-6 mm; the
non-absorbable polypropylene tape, which is 11 mm wide
and 450 mm long with a plastic sheath cover, is fixed to the
needles. Polypropylene sling procedures can be differentiated
by the implantation technique, and most importantly, by the
conformation of the polypropylene mesh that is used (11).
Synthetic meshes are characterized on the basis of pore size.
Pore sizes larger than 75  m are known as ‘macroporous’,
whereas those less than 10  m are known as ‘microporous’.
The tape of the IRIS system is polypropylene monofilament
mesh (Trelex; Meadox Medicals, Oakland, NJ/Boston Scien-
tific, NJ, U.S.A.), and the diameter of the pore size is greater
than 75  m such as the tape of TVT or SPARC (Suprapubic
arch) (12). The larger pore size and monofilament nature of
this mesh allows connective tissue ingrowth into the mesh
with collagen deposition around the polypropylene fiber and
this is thought to decrease the risk of infection by allowing








at 7 days at 1 yr at 3 yr
MFR 27.6±9.8 20.7±7.6* 24.4±7.0
� 26.2±5.7
� 26.4±7.4 21.5±7.2* 22.7±6.4* 25.3±5.2
�
PVR 11.1±6.1 23.6±16.3* 13.0±8.4
� 15.7±8.7* 12.5±9.0 24.5±13.6* 14.8±12.5
� 16.8±10.5
�
Table 3. Preoperative and postoperative uroflowmetry results
Values are presented as mean±standard deviation. Data were evaluated using Student’s t-test. 
*p<0.05 compared with Preop; 
� p>0.05 compared with Preop. 
IRIS, Innovative replacement of incontinence surgery; TVT, Tension-free vaginal tape; MFR, maximal flow rate; AFR, average flow rate; PVR, post-void
residual urine volume.
Values are presented as number (%). Data were evaluated using chi-
square test. *p>0.05 compared with TVT.
IRIS, Innovative replacement of incontinence surgery; TVT, Tension-free
vaginal tape.
IRIS (n=34)
at 1 yr at 3 yr
TVT (n=32)
at 1 yr at 3 yr
Success rate 33 (97.1)* 32 (94.1)* 31 (96.9) 30 (93.8)
Cured 30 (88.2)* 29 (85.3)* 31 (96.9) 29 (90.6)
Improved 3 (8.8)* 3 (8.8)* 0 (0.0) 1 (3.1)
Fail 1 (2.9)* 2 (5.9)* 1 (3.1) 2 (6.3)
Satisfaction rate 32 (94.1)* 31 (91.2)* 31 (93.8) 29 (90.6)
Very satisfied 30 (88.2)* 29 (85.3)* 30 (93.8) 28 (87.5)
Satisfied 2 (5.9)* 2 (5.9)* 1 (3.1) 1 (3.1)
So-so 1 (2.9)* 1 (2.9)* 0 (0.0) 1 (3.1)
Dissatisfied 1 (2.9)* 2 (5.9)* 1 (3.1) 2 (6.3)
Table 4. Success and satisfaction rates
Values are presented as number (%). Data were evaluated using chi-
square test. 
IRIS, Innovative replacement of incontinence surgery; TVT, Tension-free
vaginal tape.
IRIS (n=34) TVT (n=32) p value
Overall complication rate 7 (20.6) 7 (21.9) 0.898
Perioperative complications
Bladder injury  3 (8.8) 3 (9.4) 0.938
Postoperative complications
De novo urge symptoms 2 (5.9) 3 (9.4) 0.592
Voiding difficulties 1 (2.9) 1 (3.1) 0.965
Erosion 1 (2.9) 0 (0.0) 0.328
Table 5. Perioperative and postoperative complications500 C.-J. Yoon, H.-C. Jung
and macrophages into the graft to phagocytose bacteria (13).
Moreover, the IRIS polypropylene monofilament tape is more
densely threaded and less extensible than TVT. Accordingly,
in the IRIS procedure, the mesh can no longer be moved once
in place, and this allows a possibly higher success rate in the
long-term results.
The success rate of 93.8% at 3-yr follow-up in the TVT
group is comparable to the previously published reports (6,
14). Furthermore, in our study the IRIS and TVT did not
have statistically significant differences in the success rates,
satisfaction rates, or complication rates. The high long-term
success rates and low complication rates of the IRIS proce-
dure show that this procedure was safe and effective, mak-
ing this technique the optimal surgical treatment for female
stress urinary incontinence. For the patients followed for a
minimum of 3 yr, we found that the success (cured and im-
proved) rate was maintained from 97.1% at 1 yr to 94.1%
at 3 yr.
According to Ulmsten (15), and Lo et al. (16), the number
of failures of TVT was increased for the intrinsic sphinctor
deficiency (ISD) patients compared to that for the patients
with genuine stress incontinence without ISD. In our study,
two patients in each group, who were regarded as treatment
failures, had low MUCP (14/18/24/26 cmH2O) and VLPP
(48/53/57/62 cmH2O) values.
Although the TVT procedure creates dynamic urethral
kinking without compressing the urethra at rest (17), 2.8%
to 14% of the patients later develop obstructive voiding symp-
toms (18). According to another paper, the highest obstruc-
tion-inducing risk is the surgeon himself according to ten-
sioning the tape too much (19). In our study, one patient in
each group has transient voiding difficulties; this resolved
within 1-2 weeks without release or resection of the tape.
When evaluating the uroflowmetry indices and voiding symp-
toms after the IRIS or TVT procedures, we found that the
maximal flow rate decreased significantly after surgery, but
during the 3-yr follow-up, it increased up to the preoperative
levels in both groups. This might have been due to a slow,
downward displacement of the tape and the surrounding
tissues, which resulted in less marked urethral compression,
or it may have been due to chronic obstruction that resulted
in progressive detrusor hypertrophy and this allowed better
emptying function. 
Bladder perforation is one of the most frequently observed
complications after the TVT procedure. A recent review of
the TVT literature showed the bladder perforation rate ranged
from 0.7% to 19% (14, 20, 21). We observed that three pa-
tients in each group (8.8% vs. 9.3%, respectively) experienced
bladder perforation, although most of these patients only
needed an indwelling catheter for a short period of time.
For analyzing the changes in urge incontinence and over-
active bladder symptoms after the TVT procedure, Segal et
al. reported that 4.3% and 9.1% of patients with pure stress
urinary incontinence were found to have developed de novo
urgency and de novo incontinence, respectively (22). In our
study, two patients (5.8%) in the IRIS group and three (9.3%)
in the TVT group were found to have developed de novo
urgency or de novo urge incontinence. Of the patients with
mixed urinary incontinence, the urge component resolved
in 66.7% and 60.0% in both groups, respectively. However,
there was no long-term voiding dysfunction after surgery,
nor were there bowel, nerve or major vessel injuries in either
groups.
In conclusion, the objective surgical outcomes and various
complications of the IRIS and TVT procedures, at 3-yr follow-
up, were not significantly different in this study. The high
long-term success rates and low complication rates of the IRIS
procedure show that this procedure is effective and safe for
the treatment of stress and mixed urinary incontinence. 
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